Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins

scientific article published on November 1998

Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1099/0022-1317-79-11-2631
P698PubMed publication ID9820138
P5875ResearchGate publication ID13466835

P2093author name stringLin B
Wright PJ
Davidson AD
Pryor MJ
Gualano RC
P407language of work or nameEnglishQ1860
P921main subjectDengue virusQ476209
P304page(s)2631-2639
P577publication date1998-11-01
P1433published inJournal of General VirologyQ6295245
P1476titleGrowth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins
P478volume79 ( Pt 11)

Reverse relations

cites work (P2860)
Q27486779A Single N-Linked Glycosylation Site in the Japanese Encephalitis Virus prM Protein Is Critical for Cell Type-Specific prM Protein Biogenesis, Virus Particle Release, and Pathogenicity in Mice
Q90230085An Attenuated Zika Virus Encoding Non-Glycosylated Envelope (E) and Non-Structural Protein 1 (NS1) Confers Complete Protection against Lethal Challenge in a Mouse Model
Q27469932Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein
Q27486787Changing the Protease Specificity for Activation of a Flavivirus, Tick-Borne Encephalitis Virus
Q40010777Characterization of Asn130-to-Ala mutant of dengue type 1 virus NS1 protein
Q27473070Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis
Q40204571Critical role of Dengue Virus NS1 protein in viral replication
Q40481579Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses.
Q40044088Dengue Virus Glycosylation: What Do We Know?
Q28278881Dengue virus life cycle: viral and host factors modulating infectivity
Q33198586Determination of the disulfide bond arrangement of dengue virus NS1 protein
Q40374575Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus
Q43780962Effect of site-directed asparagine to isoleucine substitutions at the N-linked E1 glycosylation sites on rubella virus viability
Q27469756Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase
Q38289956Flavivirus reverse genetic systems, construction techniques and applications: a historical perspective
Q40520518Histidine 39 in the dengue virus type 2 M protein has an important role in virus assembly
Q30235062Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis
Q27469687Infection of human cells by dengue virus is modulated by different cell types and viral strains
Q27472878Infectious cDNA clone of the epidemic west nile virus from New York City
Q35893162Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Q40192970Molecular Docking Based Screening of Plant Flavonoids as Dengue NS1 Inhibitors
Q23311397Molecular biology of flaviviruses
Q35613317Molecular determinants of virulence: the structural and functional basis for flavivirus attenuation
Q27469868Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication
Q40601257Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus
Q35745411Mutation of Putative N-Glycosylation Sites on Dengue Virus NS4B Decreases RNA Replication
Q34952610N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement
Q40448705Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection.
Q34807255Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy
Q33812419Perspectives for the treatment of infections with Flaviviridae
Q40593098Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein
Q38174301Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology
Q40264220Secreted expression and purification of dengue 2 virus full-length nonstructural glycoprotein NS1 in Pichia pastoris
Q40396699Super induction of dengue virus NS1 protein in E. coli
Q56916580The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis
Q38157833Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease